Introduction
============

One of the most common outcomes of thoracic lung resections are air leaks arising from lung parenchyma. Postoperatively, the incidence of air leaks immediately after resection has been reported to range from 28% to 60% with the majority spontaneously resolving by postoperative day 4.[@b1-ceor-9-373] Because most air leaks are self-limited, controlled with a standard chest tube, and spontaneously resolve several days after surgery, only prolonged air leaks (PALs) (lasting for \>5 or 7 days) have been considered a surgical complication.[@b1-ceor-9-373],[@b2-ceor-9-373] This definition of PALs does not consider air leaks lasting \<5 or 7 days but result in prolonged hospitalization. Additionally, this definition does not consider the type of lung resection. The expected length of stay (LOS) for wedge resections (4--7 days) is significantly less than that for lobectomy (6--10 days); thus, air leaks of shorter duration may be more important in wedge resections as they may contribute more often to additional hospital days.[@b3-ceor-9-373]--[@b5-ceor-9-373] A more general definition of any air leak complications (aALCs) would include air leaks of any duration that result in a clinical intervention or prolonged hospitalization.

Research has focused on the clinical and economic effects of PALs with the incidence estimated at between 8% and 26% in patients undergoing major pulmonary resection.[@b6-ceor-9-373]--[@b9-ceor-9-373] The incidence of PALs varies by resection type with segmentectomy having the highest incidence (10--15%), followed by lobectomy (9--13%) and wedge resection (3.3%).[@b6-ceor-9-373],[@b10-ceor-9-373]--[@b14-ceor-9-373] COPD is one of the major risk factors for PALs.[@b7-ceor-9-373],[@b13-ceor-9-373],[@b15-ceor-9-373] A PAL has been shown to be associated with a complicated postoperative course, a longer hospital stay,[@b6-ceor-9-373] and higher rates of readmissions and other complications (such as pneumonia and respiratory failure).[@b1-ceor-9-373],[@b16-ceor-9-373] Because of the focus on PALs, there is a paucity of research evaluating the effect of any air leak and the potential impact on resource utilization.

Recent advances in surgical techniques (especially video-assisted thoracoscopic surgery, VATS)[@b17-ceor-9-373]--[@b20-ceor-9-373] and postoperative care (such as improved pain management[@b21-ceor-9-373] and more optimal chest tube management[@b22-ceor-9-373]) have decreased morbidities and hospital LOS and facilitated rapid return to baseline functional levels.[@b23-ceor-9-373],[@b24-ceor-9-373] Because of this trend of shorter hospitalizations, air leaks that previously would have resolved prior to the patient being ready for discharge and have little noticeable impact on LOS may now contribute to prolonged hospitalization and subsequent complications. The incidence of aALCs and their impact on health care utilization have not been well studied. Hence, the objective of this study is to identify the risk factors of any air leak and evaluate its clinical impact and economic burden in patients undergoing thoracic surgery.

Methods
=======

Study design and cohort
-----------------------

This retrospective cohort study utilized data on lung resections, performed from 2012 to 2014, present in the Premier Perspective^®^ database (Premier, Inc., Charlotte, NC, USA). The procedure codes of the International Classification of Diseases, Ninth Revision (ICD-9), were utilized to identify all patients who underwent elective primary lobectomy (32.41, 32.49), segmentectomy (32.30, 32.39), and wedge resections (32.20, 32.28, 32.29) ([Table S1](#SD1-ceor-9-373){ref-type="supplementary-material"}).

Database
--------

The Premier Perspective database utilized in this study is a hospital billing database that contains information on clinical coding, hospital cost, and patient billing data from \>600 hospitals in the US. These hospitals are deemed nationally representative with respect to bed size, geographical region, location (urban/rural), and teaching hospital status. The database contains information on medications, laboratory and diagnostic procedures, and primary and secondary diagnoses for each patient's hospitalization. Approval by an Institutional Review Board was not necessary to conduct this study, as data within the Premier database are de-identified in accordance with the Health Insurance Portability and Accountability Act. No patient consent was required for this retrospective analysis.

Inclusion and exclusion criteria
--------------------------------

Patients were included if they were undergoing elective thoracic lung resections (index), that is, wedge resection, segmentectomy, or lobectomy, regardless of the approach (VATS or thoracotomy), in an inpatient setting, and were 18 years or older at the time of index. Patients were excluded if the route of admission was transfer from a different facility or if they did not have an assigned discharge disposition. Additional exclusion criteria included evidence of pregnancy or if they underwent both a lobectomy and a segmentectomy procedure.

Variables
---------

The primary outcomes of interests were hospital LOS, operating room time (ORT), overall hospital costs (adjusted to 2014 US dollars), and mortality. aALCs were defined as a composite of air leak (ICD-9 codes=512.2, 512.84) and pneumothorax (ICD-9 codes=512.1, 512.89) occurring at any time during the hospitalization. Unlike LOS and overall hospital costs, ORT temporally precedes aALCs within a patient's course of care. The objective of this study was to understand the health care utilization associated with aALCs irrespective of the temporal relationship, and hence, ORT was included in the analyses.

Other covariates assessed in this study are given as follows.

### Patients' demographic characteristics

These included age, gender, race (categorized as White, Black, Hispanic, other, and unknown), and marital status (categorized as married, single, and other).

### Patients' comorbidities

These included Charlson comorbidity score, which was assessed using Deyo--Charlson Comorbidity Index, and specific comorbidity categories, such as cardiac arrhythmia, congestive heart failure, peripheral vascular diseases, myocardial infarction, cardiovascular diseases, pulmonary circulation disorder, obesity, diabetes, hypertension, depression, renal failure, and COPD ([Table S1](#SD1-ceor-9-373){ref-type="supplementary-material"}). The Charlson Comorbidity Index (CCI) is a method of categorizing comorbidities of patients based on the ICD diagnosis codes found in administrative data, such as hospital abstracts data. Each comorbidity category has an associated weight (from 1 to 6), based on the adjusted risk of mortality or resource use, and the sum of all the weights results in a single comorbidity score for a patient. The higher CCI score indicates higher likelihood that the predicted outcome will result in mortality or higher resource use.[@b25-ceor-9-373]

### Procedural characteristics

These included payer type (categorized as commercial, Medicare, or Medicaid), year of surgery (2012, 2013, or 2014), surgical approach (VATS, thoracotomy), and robotic assistance.

### Provider characteristics

These included location (urban/rural), teaching status (whether the hospital is a teaching hospital or not), geographical region (South, Northeast, Midwest, and West), hospital size (small, medium, large), bed size (categorized as 1--100 beds, 100--300 beds, 301--500 beds, and \>500 beds), costing method[@b26-ceor-9-373] (ratio of cost to charge vs procedural costing), hospital lung resection procedure volume from 2012 to 2014 (categorized as 1--50, 51--150, 151--300, and \>300 surgeries), and physician specialty (categorized as thoracic surgeon, cardiac surgeon, general surgeon, or other).

Statistical analysis
--------------------

Descriptive analysis (mean and standard deviation for continuous variables and proportions for categorical variables) was used to describe all the study variables. Bivariate analyses (Student's *t*-test and Chi square test) were conducted to assess the differences in outcomes for patients with and without aALCs. Risk factors for aALCs were analyzed utilizing logistic regression accounting for clustering within hospitals. Generalized estimating equation (GEE) models were used to explore the impact of aALCs on LOS, ORT, overall hospital costs, and mortality after accounting for clustering within hospitals and controlling for patient, provider, and procedure characteristics. All three models had a log link function. LOS and ORT were modeled with a negative binomial distribution, and overall hospital costs were modeled with a gamma distribution. The multivariable models evaluated the overall sample and also by resection type. A sensitivity analysis was performed to evaluate the effect of the present-on-admission (POA) flag. The POA flag, which indicates whether an ICD-9 diagnosis code was a preexisting comorbidity or an incident event, was utilized to identify aALC events. The incidence of aALCs was adjusted based on a revised algorithm that excluded aALCs with a POA flag, and GEE models were repeated with the revised algorithm. Statistical significance was set a priori at *p*\<0.05 (two-sided). All analyses were conducted using SAS for Windows, Version 9.4 (SAS Institute Inc., Cary, NC, USA).

Results
=======

Of the 21,150 patients, 10,946 underwent lobectomy (46.4% VATS approach), 1,788 underwent segmentectomy (62.4% VATS approach), and 8,416 underwent wedge resection (78.8% VATS approach). Overall, 37% of patients were 65 years or older with more females than males (53% vs 47%), and the majority were primarily White (76%) and married (51%). Hypertension was the most prevalent comorbid condition among this study population (61%) followed by diabetes (21%) and COPD (12%). [Tables 1](#t1-ceor-9-373){ref-type="table"} and [2](#t2-ceor-9-373){ref-type="table"} show the baseline patient and provider characteristics, respectively, by resection type. The mean (SD) LOS for all thoracic surgeries was 5.7 (5.4) days, with an average ORT of 211 (190) min and overall hospital costs of \$22,163 (\$83,619). The overall mortality was 1.06% (95% CI \[0.92, 1.20\]) and varied by resection type: lobectomy 1.42% (95% CI \[1.19, 1.64\]), segmentectomy 0.95% (95% CI \[0.50, 1.40\]), and wedge resection 0.62% (95% CI \[0.45, 0.79\]).

Incidence and risk factors of aALCs
-----------------------------------

The overall incidence of aALCs was 24.26% (95% CI \[23.68, 24.83\]) and varied by resection type: lobectomy 29.20% (95% CI \[28.35, 30.05\]), segmentectomy 22.04% (95% CI \[20.11, 23.96\]), and wedge resection 18.30% (95% CI \[17.47, 19.12\]).

In the multivariable logistic regression analysis (presented in [Figures 1](#f1-ceor-9-373){ref-type="fig"} and [2](#f2-ceor-9-373){ref-type="fig"}), relevant risk factors for aALCs included the following: age group of 18--44 years compared to ≥75 years (odds ratio \[OR\]=1.37, 95% CI \[1.09, 1.71\]), CCI scores of 0 (OR=0.65, 95% CI \[0.56, 0.76\]) and 3--4 compared to ≥5 (OR=1.26, 95% CI \[1.16, 1.37\]), procedures performed in year 2012 compared to 2014 (OR=0.85, 95% CI \[0.75, 0.97\]), Northeast region compared to West (OR=0.69, 95% CI \[0.50, 0.96\]), thoracotomy approach compared to VATS (OR=1.13, 95% CI \[1.01, 1.27\]), male gender (OR=1.11, 95% CI \[1.04, 1.18\]), and the presence of COPD (OR=1.80 \[1.63, 1.99\]). Interestingly, other comorbidities including hypertension, obesity, and diabetes were associated with decreased odds of aALCs. Both segmentectomy (OR=0.77, 95% CI \[0.67, 0.89\]) and wedge resection (OR=0.73, 95% CI \[0.66, 0.80\]) had lower odds of aALCs compared to lobectomy.

Impact of aALCs on health care utilization and mortality
--------------------------------------------------------

Results from the bivariate analysis showed that the unadjusted mean (SD) for LOS, ORT, and overall hospital costs for patients with and without aALCs was 8.07 (6.12) days vs 4.94 (4.83) days, 231 (245) min vs 205 (169) min, and \$29,213 (\$167,076) vs \$19,905 (\$16,509), respectively (all with *p*\<0.001). Unadjusted mortality was found to be 1.85% among patients with aALCs compared to 0.81% among patients without aALCs (*p*\<0.001). The differences in unadjusted means for LOS, ORT, mortality, and overall hospital costs remained significantly higher among patients with aALCs across types of resection.

The adjusted mean LOS (days) in the multivariable analysis was 42.2% longer for patients with aALCs compared to those without aALCs ([Figure 3](#f3-ceor-9-373){ref-type="fig"}). The adjusted mean ORT (min) was 6.4% longer for patients with aALCs compared to those without aALCs ([Figure 4](#f4-ceor-9-373){ref-type="fig"}). Overall, the adjusted hospital costs were 28.7% higher among patients with aALCs compared to those without aALCs ([Figure 5](#f5-ceor-9-373){ref-type="fig"}). These were all statistically significant differences. Overall, aALCs were associated with increased odds of mortality (OR=1.90, 95% CI \[1.42, 2.55\]). Within lobectomy (OR=3.40, 95% CI \[1.88, 6.15\]) and wedge resection (OR=1.50, 95% CI \[1.07, 2.10\]), aALC was associated with significantly increased mortality, but no differences in segmentectomy (OR=2.05, 95% CI \[0.67, 6.25\]) were observed ([Figure 6](#f6-ceor-9-373){ref-type="fig"}).

In the sensitivity analysis, the incidence of aALCs was adjusted by excluding cases which were POA. This slightly reduced the incidence rates of aALCs (overall=21.91%; lobectomy=27.30%; segmentectomy=19.97%; wedge resection=15.32%). However, the consequent impact on resource utilization was consistent. The overall incidence of aALCs varied by type of approach (thoracotomy=27.88% vs VATS=21.90%), and the impact on resource utilization within each type of approach was similar to the overall cohort. The costs for one of the patients in the study cohort with aALC were an outlier with the hospital cost of \$11.9 million. Reanalysis of the data after excluding this patient led to consistent results for ORT and LOS. Costs were also significantly higher for the aALCs cohort, but the incremental adjusted costs decreased from \$6,338 to \$5,054.

Discussion
==========

This study aimed to address the gap in the available literature by providing more evidence on the impact of aALCs on health care utilization and mortality. To the best of knowledge, this study is the first to describe the significant burden of aALCs on hospital costs along with increased LOS and longer ORT. A longer ORT may represent a more complex operation with increased tissue manipulation and dissection which may be risk factors for aALCs. This study shows that aALCs are frequent events, occurring in 24% of all lung resections with an associated increase in LOS of 2.5 days and hospital costs of \$6,000. Additionally, the study found that aALC is associated with a significant increase in the odds of mortality. This finding differs from prior studies that evaluated PALs. This difference may be attributed to the air leak duration (5 or 7 days) requirement, which requires hospitalization during this period and is inherently biased in overestimating the effect on health care utilization.

The overall incidence of aALCs was nearly 24% and is within the range of the published literature for any air leaks (26%--48%).[@b22-ceor-9-373],[@b27-ceor-9-373],[@b28-ceor-9-373] Additionally, this aALC estimate is lower than reported PALs. A study conducted by Varela et al found the incidence of PALs (\>5 days) to be \~10%,[@b11-ceor-9-373] while others have reported the incidence in the range of 15%--18%.[@b13-ceor-9-373],[@b29-ceor-9-373] The present study identified multiple risk factors for aALCs including thoracotomy, male gender, lobectomy resections, and the presence of COPD. These are similar to risk factors identified in clinical studies.[@b30-ceor-9-373]--[@b32-ceor-9-373] Bille et al[@b27-ceor-9-373] identified multiple anatomic risk factors including resection type, pleural adhesions, and an incomplete fissure. Brunelli et al[@b13-ceor-9-373] identified risk factors for PALs after lobectomy including reduced postoperative forced expiratory volume in 1 second (FEV1), pleural adhesions, and upper lobe resections. Cerfolio et al[@b33-ceor-9-373] found FEV1, steroid use, male gender, and lobectomy resections as risk factors for air leaks. Surprisingly in the present study, diabetes, hypertension, and obesity were associated with decreased odds of aALCs. While these have not been previously shown to be risk factors for PALs, this may reflect differences in surgeon expectations or coding practices for patients with these comorbidities.

This study found that patients with aALCs were associated with a significantly increased mean LOS, a finding consistent with other previously published studies.[@b10-ceor-9-373],[@b34-ceor-9-373]--[@b36-ceor-9-373] A retrospective case series conducted by Bardell and Petsikas found that the only significant predictor of increased LOS following pulmonary resection was air leaks lasting longer than 3 days. The mean postoperative LOS for patients with PALs was 9.4 days compared to 5.2 days.[@b34-ceor-9-373] Similarly, Liang et al found that the median hospital stay was prolonged by 4 days due to PALs (\>5 days).[@b36-ceor-9-373] In a retrospective study of the Medicare Provider Analysis and Review Hospital National Limited Data Set, Wood et al[@b9-ceor-9-373] analyzed the effect of air leaks in VATS lobectomy, segmentectomy, and lung volume reduction surgery performed in 2012. The rate of air leaks was 13.6% and increased LOS by 37% and hospital costs by 14.9%. LOS for cases with a PAL was on average 2.7 days longer than those cases without an air leak diagnosis (10.0 days vs 7.3 days, respectively; *p*\<0.001). While most studies have reported the burden of air leaks in terms of LOS and mortality, only the study by Wood et al characterized the direct costs related to air leaks in the US. Similar to the present study, this study found a significantly higher total hospital costs in the air leaks group (\$22,641 vs \$18,852).[@b9-ceor-9-373] In this study, the hospital costs were calculated using the Inpatient Prospective Payment System Final Rule 2014 Standardizing File. Overall, the findings of the present study appear to show a similar association between aALCs and increased resource utilization.

Limitations of the present study are related to the use of a hospital billing database for the purpose of studying clinical outcomes research. The Premier database does not include an ICD-9 diagnosis date, so the exact onset and duration of aALCs is unknown. This makes it impossible to evaluate whether the effects seen are related to shorter duration vs PALs (e.g. PALs). Additionally, important clinical risk factors such patient body mass index, prior neo-adjuvant chemoradiation, preoperative lung function (such as forced expiratory volume), tumor size or stage, lung lobe anatomy, intraoperative pleural adhesions, and tissue quality are not available. These unmeasured patient differences may be correlated with aALCs and contribute to the increased resource utilization observed. The present analysis excluded nonelective cases which are \~20% of thoracic lung resections in the Premier sample. This proportion of elective to nonelective procedures is consistent with other published studies.[@b37-ceor-9-373],[@b38-ceor-9-373] Finally, the Premier hospital database captures \~20% of annual US inpatient discharges or \>80 million inpatient admissions with \>5 million per year since 2011 and has been described as a representative sample of inpatient admissions.[@b39-ceor-9-373] The results from this study may not be completely representative of the costs and outcomes across the entire US.

Conclusion
==========

The potential importance of shorter-duration air leaks may increase as improvements in surgical techniques and postoperative care continue to decrease the average length of hospital stay of patients after thoracic resections. Based upon these findings, the prevention and management of any air leak regardless of duration may be an important outcome to consider for improvements in clinical practice.

In conclusion, aALCs in patients undergoing lung resections are not only frequent but also associated with significant impacts on patient outcomes in terms of LOS, total hospital costs, and mortality.

Supplementary material
======================

###### 

List of diagnosis and procedure codes

  ICD-9 code                                                                   Definition                                                                           Resection type          Approach
  ---------------------------------------------------------------------------- ------------------------------------------------------------------------------------ ----------------------- ----------
  32.20                                                                        Thoracoscopic excision of lesion or tissue of lung                                   Wedge                   VATS
  32.28                                                                        Endoscopic excision or destruction of lesion or tissue of lung                       Wedge                   VATS
  32.29                                                                        Other local excision or destruction of lesion or tissue of lung                      Wedge                   Open
  32.30                                                                        Thoracoscopic segmental resection of lung                                            Segmentectomy           VATS
  32.39                                                                        Other and unspecified segmental resection of lung                                    Segmentectomy           Open
  32.41                                                                        Thoracoscopic lobectomy of lung                                                      Lobectomy               VATS
  32.49                                                                        Other lobectomy of lung                                                              Lobectomy               Open
  32.50                                                                        Thoracoscopic pneumonectomy                                                          Pneumonectomy           VATS
  32.59                                                                        Other and unspecified pneumonectomy                                                  Pneumonectomy           Open
                                                                                                                                                                                            
  **Primary outcomes (ICD-9 diagnosis codes) for any air leak complication**                                                                                                                
                                                                                                                                                                                            
  **ICD-9 code**                                                               **Definition**                                                                       **Complication type**   
                                                                                                                                                                                            
  512.2                                                                        Postoperative air leak                                                               Air leak                
  512.84                                                                       Other air leak                                                                       Air leak                
  512.1                                                                        Iatrogenic pneumothorax                                                              Pneumothorax            
  512.89                                                                       Other pneumothorax                                                                   Pneumothorax            
                                                                                                                                                                                            
  **Coding algorithm for Charlson comorbidities[@b25-ceor-9-373]**                                                                                                                          
                                                                                                                                                                                            
  **ICD-9 code**                                                               **Comorbidities**                                                                                            
                                                                                                                                                                                            
  410.x, 412.x                                                                 Myocardial infarction                                                                                        
  428.x                                                                        Congestive heart failure                                                                                     
  443.9, 441.x, 785.4, V43.4 procedure 38.48                                   Peripheral vascular disease                                                                                  
  430.x--438.x                                                                 Cerebrovascular disease                                                                                      
  290.x                                                                        Dementia                                                                                                     
  490.x--505.x, 506.4                                                          Chronic pulmonary disease                                                                                    
  710.0, 710.1, 710.4, 714.0--714.2, 714.81, 725.x                             Rheumatic disease                                                                                            
  531.x--534.x                                                                 Peptic ulcer disease                                                                                         
  571.2, 571.4--571.6                                                          Mild liver disease                                                                                           
  250.0--250.3, 250.7                                                          Diabetes without chronic complication                                                                        
  250.4--250.6                                                                 Diabetes with chronic complication                                                                           
  344.1, 342.x                                                                 Hemiplegia or paraplegia                                                                                     
  582.x, 583-583.7, 585.x, 586.x, 588.x                                        Renal disease                                                                                                
  140.x--172.x, 174.x--195.8, 200.x--208.x                                     Any malignancy, including lymphoma and leukemia, except malignant neoplasm of skin                           
  456.0--456.21, 572.2--572.8                                                  Moderate or severe liver disease                                                                             
  196.x--199.1                                                                 Metastatic solid tumor                                                                                       
  042.x--044.x                                                                 AIDS/HIV                                                                                                     

**Note:** Only select comorbidities based on bivariate analysis were included in the regression models.

**Abbreviations:** ICD-9, International Classification of Diseases, Ninth Revision; VATS, video-assisted thoracoscopic surgery.
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![Patient-related factors associated with aALC.\
**Notes:** Values represent odds ratios, and error bars represent 95% CIs. \*Charlson Comorbidity Index.[@b25-ceor-9-373]\
**Abbreviations:** aALC, any air leak complication; CCI, Charlson Comorbidity Index.](ceor-9-373Fig1){#f1-ceor-9-373}

![Provider-related factors associated with aALC.\
**Note:** Values represent odds ratios, and error bars represent 95% CIs.\
**Abbreviations:** aALC, any air leak complication; VATS, video-assisted thoracoscopic surgery; RCC, ratio of cost to charge.](ceor-9-373Fig2){#f2-ceor-9-373}

![Association between air leak and hospital LOS (overall and by resection type).\
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![Association between air leak and ORT (overall and by resection type).\
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![Association between any air leak complications and mortality.](ceor-9-373Fig6){#f6-ceor-9-373}

###### 

Baseline patient characteristics of the study cohort based on resection types

  Patient characteristics           Wedge (n=8,416), %   Segmentectomy (n=1,788), %   Lobectomy (n=10,946), %                   
  --------------------------------- -------------------- ---------------------------- ------------------------- ------- ------- -------
  **Primary diagnosis**                                                                                                         
  Cancer                            67.8                 50.0                         82.9                      81.6    94.5%   94.5%
  Pulmonary fibrosis                10.5                 19.3                         3.1                       5.1     0.7     0.9
  Other                             21.7                 30.7                         14.0                      13.3    4.8     4.5%
  **Gender**                                                                                                                    
  Female                            51.2                 53.9                         49.1                      53.8    50.3    55.4
  **Age (years)**                                                                                                               
  18--44                            6.0                  9.4                          5.2                       3.7     2.4     2.1
  45--54                            12.3                 13.8                         9.1                       9.2     9.5     9.6
  55--64                            25.4                 24.7                         27.5                      21.7    25.9    23.7
  65--74                            34.5                 32.3                         34.8                      37.4    39.6    39.8
  75+                               21.9                 19.8                         23.4                      28.0    22.7    24.8
  **Race**                                                                                                                      
  White                             78.2                 73.6                         76.3                      75.3    78.3    75.7
  Black                             7.1                  7.0                          8.5                       6.7     7.2     7.6
  Other                             14.7                 19.4                         15.2                      18.0    14.5    16.6
  **Marital status**                                                                                                            
  Single                            36.0                 34.1                         37.4                      35.1    36.6    36.1
  Married                           52.1                 50.3                         48.5                      50.1    53.2    47.6
  Other                             11.9                 15.6                         14.1                      14.8    10.2    16.3
  **Payer**                                                                                                                     
  Commercial                        32.3                 38.4                         31.7                      31.0    29.1    30.3
  Medicaid                          7.0                  6.6                          6.1                       4.4     5.8     5.6
  Medicare                          58.1                 53.3                         60.6                      63.3    63.1    62.5
  Other                             2.6                  1.7                          1.6                       1.3     2.0     1.7
  **Year**                                                                                                                      
  2012                              38.3                 34.0                         39.7                      35.7    35.6    32.0
  2013                              31.4                 31.8                         29.2                      31.4    34.6    32.6
  2014                              30.2                 34.2                         31.1                      33.0    29.8    35.4
  **Charlson Comorbidity Index**                                                                                                
  0                                 14.1                 20.4                         6.5                       8.2     3.2     4.0
  1--2                              27.4                 36.2                         24.7                      32.3    24.2    29.3
  3--4                              28.0                 20.5                         40.9                      36.0    42.8    43.3
  ≥5                                30.5                 22.9                         27.8                      23.4    29.8    23.5
  **Specific comorbid condition**                                                                                               
  COPD                              11.94                11.05                        13.69                     12.01   12.16   10.87
  Diabetes                          22.59                19.09                        22.77                     18.46   22.27   20.04
  Hypertension                      60.87                54.60                        63.69                     60.30   64.96   62.55
  Renal failure                     7.29                 5.50                         7.14                      6.45    7.21    5.83
  Obesity                           13.68                13.06                        11.76                     13.98   11.77   11.84

**Abbreviation:** VATS, video-assisted thoracoscopic surgery.

###### 

Baseline provider characteristics of the study cohort based on resection types

  Provider characteristics                        Wedge (n=8,416), %   Segmentectomy (n=1,788), %   Lobectomy (n=10,946), %                 
  ----------------------------------------------- -------------------- ---------------------------- ------------------------- ------ ------ ------
  **Teaching hospital**                           45.0                 61.0                         47.8                      58.5   45.5   62.9
  **Geographic area of USA**                                                                                                                
  Midwest                                         26.8                 17.1                         22.3                      10.1   25.8   14.7
  Northeast                                       12.1                 32.9                         11.3                      33.1   11.0   28.8
  South                                           47.4                 36.1                         47.8                      43.4   46.9   43.0
  West                                            13.7                 13.9                         18.6                      13.4   16.3   13.6
  **Urban hospital**                              89.2                 93.5                         92.0                      92.7   88.6   95.7
  **Hospital size**                                                                                                                         
  Small                                           3.3                  4.5                          3.0                       4.1    3.2    4.4
  Medium                                          12.8                 12.7                         14.1                      12.6   12.7   11.6
  Large                                           83.9                 82.8                         82.9                      83.2   84.1   84.1
  **Hospital bed size**                                                                                                                     
  Bed size 1--300                                 28.7                 19.4                         22.0                      23.2   23.0   17.2
  Bed size 301--500                               40.2                 39.0                         47.9                      31.5   43.8   33.4
  Bed size \>500                                  31.1                 41.7                         30.1                      45.3   33.2   49.4
  **Number of thoracic surgeries (2012--2014)**                                                                                             
  1--50                                           30.7                 17.1                         26.6                      16.0   26.0   13.3
  51--150                                         42.8                 41.7                         42.9                      42.8   46.6   45.3
  151--300                                        20.7                 20.4                         26.9                      17.9   23.0   20.4
  \>300 surgeries                                 5.8                  20.8                         3.6                       23.2   4.4    21.0
  **Cost type**                                                                                                                             
  Procedural                                      74.9                 72.4                         72.0                      67.7   75.7   73.0
  RCC                                             25.1                 27.6                         28.0                      32.3   24.3   27.0
  **Physician specialty**                                                                                                                   
  Thoracic surgeon                                63.1                 64.4                         65.0                      65.1   63.3   64.1
  Cardiac surgeon                                 19.8                 13.6                         16.7                      9.3    20.1   13.4
  General surgeon                                 10.3                 14.3                         10.0                      13.4   9.1    11.6
  Other                                           6.8                  7.6                          8.3                       12.3   7.6    10.9

**Abbreviations:** VATS, video-assisted thoracoscopic surgery; RCC, ratio of cost to charge.
